Synthetic Stem Cell Microspheres for Immune-Safe Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell therapies face challenges such as immune compatibility issues, risk of malignant tumor formation, transmission of infectious processes, and the need for complex in vitro culture and isolation, which limits their clinical application and efficiency.
Innovation Solution
Development of biodegradable polymeric microspheres encapsulating secretome active agents, such as growth factors and cytokines, to mimic the paracrine function of stem cells, providing a tailored therapeutic effect without immunological responses and the risks associated with traditional stem cell therapies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional stem cell therapy is used to achieve tissue repair and regeneration, then therapeutic effect is improved, but immune compatibility issues and rejection reactions occur
Solution Approach 1:
The patent extracts only the beneficial secretome components (growth factors, cytokines, exosomes) from stem cells and encapsulates them in biodegradable polymeric microspheres. This separation removes the immunogenic cellular components while retaining the therapeutic paracrine factors, thereby maintaining therapeutic effect while eliminating immune compatibility issues
Solution Approach 2:
The patent creates a synthetic artificial stem cell system that copies the essential therapeutic function of real stem cells - the paracrine secretion of growth factors and cytokines. By encapsulating these secreted factors in microspheres, the system mimics stem cell therapy without using actual cells, thus avoiding immune rejection while preserving therapeutic benefits
2Reliability
If traditional stem cell therapy is used to achieve tissue regeneration, then therapeutic effect is improved, but risk of malignant tumor formation increases
Solution Approach 1:
The patent extracts only the secretome components responsible for therapeutic effects (growth factors, cytokines, exosomes) while leaving behind the stem cell nucleus and other components capable of uncontrolled proliferation. The encapsulated microspheres deliver only the beneficial secreted factors without any proliferative capacity, thereby eliminating tumor formation risk while maintaining regenerative therapy benefits
3Reliability
If traditional stem cell therapy is used to achieve tissue repair, then therapeutic effect is improved, but transmission of infectious processes risk increases
Solution Approach 1:
The patent extracts the secretome components from stem cells and encapsulates them in synthetic polymeric microspheres. This process eliminates any viral or bacterial contaminants that might be present in cultured stem cells, as the microspheres contain only purified growth factors, cytokines, and exosomes without any living cellular material capable of transmitting infections
Solution Approach 2:
The patent uses biodegradable polymeric microspheres that degrade into harmless byproducts after delivering their therapeutic cargo. These synthetic carriers have no metabolic activity and cannot transmit infections, providing a safe, disposable alternative to living stem cells that carry infection risks
4Reliability
If traditional stem cell therapy is used to achieve tissue regeneration, then therapeutic effect is improved, but device complexity increases due to need for isolation and in vitro culture
Solution Approach 1:
The patent performs preliminary encapsulation of secretome components within biodegradable polymeric microspheres before administration. This pre-packaging eliminates the need for complex in vitro culture and isolation procedures at the time of treatment, as the therapeutic agents are already prepared and protected within the microspheres, ready for direct implantation or injection
Solution Approach 2:
The patent creates a simplified synthetic system that copies only the essential therapeutic function of stem cells - the delivery of growth factors and cytokines. By using pre-formed microspheres containing these factors, the system eliminates the complex biological processes of cell isolation, culture, and maintenance required for traditional stem cell therapy
5Reliability
If traditional stem cell therapy is used to achieve tissue repair, then therapeutic effect is improved, but loss of time increases due to culture and passage requirements
Solution Approach 1:
The patent performs preliminary encapsulation of secretome components within biodegradable polymeric microspheres in advance of clinical use. This pre-preparation eliminates the time-consuming in vitro culture and passage procedures required for traditional stem cell therapy, allowing the therapeutic agents to be ready for immediate administration without extended cultivation periods
Data Source
AI summary
This disclosure relates to an engineered a novel synthetic artificial stem cell (SASC) system which mimics the paracrine effect of the stem cell secretome and provides tailorability of the composition for targeted tissue regeneration. This novel SASC system demonstrates the feasibility of developing a completely synthetic, tailorable stem cell secretome which reinforces the possibility of developing a new therapeutic strategy that provides better control over targeted tissue engineering applications. Disclosed herein are biodegradable polymeric microspheres that have been used to encapsulate secretome active agents. These microspheres mimic or have the potential to result in a greater therapeutic paracrine effect compared to stem cells, without the added risk of immunological response or the extra pro-inflammatory, antagonistic or inert factors/cytokines. The compositions may be personalized to any disease and/or individual, therefore, adding a much needed element to therapeutics.